Armata Pharmaceuticals In... (ARMP)
2.00
0.01 (0.74%)
At close: Mar 03, 2025, 3:59 PM
1.99
-0.50%
After-hours: Mar 03, 2025, 04:00 PM EST
Armata Pharmaceuticals Income Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY09 | FY08 | FY07 | FY06 | FY05 | FY04 | FY03 | FY02 | FY01 | FY00 | FY99 | FY98 | FY97 | FY96 | FY95 | FY94 | FY93 |
| Revenue | 4.53M | 5.51M | 4.47M | 823K | n/a | n/a | 115K | 260K | 475K | 409K | 325K | 664K | 12.17M | 8.72M | 10.33M | 9.86M | 6.87M | 9.65M | 14.07M | 19.33M | 18.88M | 11.4M | 6.8M | 7.2M | 900K | 2.3M | 100K | 400K | 100K |
| Cost of Revenue | 33.77M | 892K | 20.02M | 14.44M | 1.35M | 1.35M | 374K | 369K | n/a | n/a | n/a | n/a | 12.17M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.77M | -1.6M | -1.6M | -1.6M | -1.9M | -1.4M | -1.3M | -400K |
| Gross Profit | -29.24M | 4.62M | -15.54M | -13.62M | -1.35M | -1.35M | -259K | -109K | 475K | 409K | 325K | 664K | n/a | 8.72M | 10.33M | 9.86M | 6.87M | 9.65M | 14.07M | 19.33M | 18.88M | 13.18M | 8.4M | 8.8M | 2.5M | 4.2M | 1.5M | 1.7M | 500K |
| Operating Income | -40.89M | -36.95M | -23.82M | -21.59M | -19.75M | -12.52M | -16.16M | -23.38M | -10.23M | -14.11M | -14.99M | -4.02M | 1.69M | -21.17M | -16.55M | -36.73M | -19.35M | -15.17M | -13.8M | -22.74M | -28.6M | -15.3M | -11.1M | -9.1M | -14.9M | -12.1M | -10.4M | -8.3M | -5.4M |
| Interest Income | 179K | 29K | 5K | 28K | 96K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 279K | 428K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Pretax Income | -69.05M | -36.92M | -23.16M | -22.18M | -19.48M | -12.44M | -14.14M | -19.39M | -589K | 23.11M | -58.41M | -4.26M | 7.95M | -20.72M | -16.13M | -33.99M | -19.2M | -14.26M | -14.83M | -23.77M | -27.17M | -47.66M | -26.7M | -8.7M | -14.2M | -26M | -9.9M | -8.4M | -5.1M |
| Net Income | -69.05M | -36.89M | -23.22M | -22.82M | -19.02M | -12.11M | -12.84M | -18.84M | -516K | 23.11M | -58.41M | -1.11M | 7.95M | -20.72M | -16.13M | -33.99M | -19.2M | -14.26M | -14.83M | -23.77M | -27.17M | -47.66M | -26.7M | -8.7M | -14.2M | -26M | -9.9M | -8.4M | -5.1M |
| Selling & General & Admin | 11.65M | 7.44M | 8.28M | 7.97M | 9.27M | 5.7M | 7.59M | 8.41M | 6.71M | 8.71M | 8.81M | 3.21M | n/a | 5.82M | 7.03M | 6.38M | 6.31M | 6.65M | 5.49M | 8.07M | 6.2M | 5.71M | 3.6M | 3M | 2.8M | 2.9M | 2.3M | 1.9M | 5.5M |
| Research & Development | 33.77M | 35.02M | 20.02M | 14.44M | 9.82M | 4.89M | 2.88M | 5.68M | 3.99M | 5.8M | 6.5M | 1.48M | n/a | 15.18M | 17.71M | 14.48M | 18.2M | 17.29M | 17.2M | 31.32M | 31.55M | 19.31M | 14.3M | 13.3M | 13M | 11.5M | 8.2M | 6.8M | n/a |
| Other Expenses | -33.77M | -5.51M | -4.47M | -823K | -844K | 1.93M | 6K | -554K | -302K | 1.86M | n/a | 133K | 10.48M | 8.88M | 2.15M | 23.72M | 1.71M | 884K | 5.19M | 365K | 9.73M | 3.46M | 1.6M | 1.6M | 1.6M | 1.9M | 1.4M | 1.3M | 400K |
| Operating Expenses | 11.65M | 36.95M | 23.82M | 21.59M | 19.09M | 10.59M | 10.47M | 14.09M | 10.7M | 14.52M | 15.31M | 4.69M | 10.48M | 21M | 24.74M | 44.59M | 24.51M | 23.94M | 22.69M | 39.75M | 47.48M | 28.48M | 19.5M | 17.9M | 17.4M | 16.3M | 11.9M | 10M | 5.9M |
| Interest Expense | 2.63M | 29K | 64K | 628K | 931K | n/a | n/a | n/a | n/a | n/a | 2.86M | 339K | n/a | n/a | 1K | 411K | 512K | 476K | 1.21M | 1.42M | 452K | 265.65K | n/a | 300K | n/a | 400K | 300K | 200K | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 289K | 1.86M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -8,067B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 45.42M | 36.95M | 23.82M | 21.59M | 19.09M | 10.59M | 10.47M | 14.09M | 10.7M | 14.52M | 15.31M | 4.69M | 10.48M | 21M | 24.74M | 44.59M | 24.51M | 23.94M | 22.69M | 39.75M | 47.48M | 26.71M | 17.9M | 16.3M | 15.8M | 14.4M | 10.5M | 8.7M | 5.5M |
| Income Tax | n/a | -29K | 64K | 634K | -454K | -328K | -1.3M | -556K | -73K | -37.22M | 43.42M | -3.15M | n/a | 20.72M | 16.13M | 33.99M | 19.2M | 14.26M | 14.83M | 23.77M | 27.17M | 47.66M | 26.7M | 8.7M | 14.2M | 26M | 9.9M | 8.4M | 5.1M |
| Shares Outstanding (Basic) | 36.08M | 34.29M | 24.1M | 16.42M | 7.83M | 1.36M | 456.25K | 70.28K | 38.65K | 26.76K | 14.46K | 6.86K | 2.94K | 2.85K | 2.36K | 1.4K | 1.22K | 1.14K | 11.5K | 9.15K | 8.79K | 7.55K | 6.43K | 5.33K | 4.04K | 3.28K | 2.11K | 1.2K | 26.08K |
| Shares Outstanding (Diluted) | 36.08M | 34.29M | 24.1M | 16.42M | 7.83M | 1.36M | 469.58K | 70.28K | 38.65K | 42.05K | 14.46K | 6.86K | 2.94K | 2.85K | 2.36K | 1.4K | 1.22K | 1.14K | 11.5K | 9.15K | 8.79K | 7.55K | 6.43K | 5.33K | 4.04K | 3.28K | 2.11K | 1.2K | 26.08K |
| EPS (Basic) | -1.91 | -1.08 | -0.96 | -1.39 | -2.43 | -8.9 | -28.14 | -268.06 | -13.35 | 589.40 | -4.04K | -161.76 | 2.71K | -7.27K | -6.84K | -24.31K | -15.7K | -12.56K | -1.29K | -2.6K | -3.09K | -6.31K | -4.15K | -1.63K | -3.52K | -7.92K | -4.7K | -7K | -195.58 |
| EPS (Diluted) | -1.91 | -1.08 | -0.96 | -1.39 | -2.43 | -8.9 | -27.34 | -268.06 | -13.35 | -326.2 | -4.04K | -161.76 | 2.71K | -7.27K | -6.84K | -24.31K | -15.7K | -12.56K | -1.29K | -2.6K | -3.09K | -6.31K | -4.15K | -1.63K | -3.52K | -7.92K | -4.7K | -7K | -195.58 |
| EBITDA | -39.92M | -36.05M | -22.65M | -20.44M | -19.75M | -9.54M | -9.98M | -13.46M | -10.23M | -14.11M | -61.6M | -3.86M | 7.95M | -11.77M | -13.8M | -32.86M | -17.37M | -12.49M | -6.19M | -16.8M | -19.91M | -42.34M | -9.5M | -7.5M | -13.3M | -10.2M | -9M | -7M | -5M |
| Depreciation & Amortization | 972K | 892K | 1.17M | 1.11M | 1.35M | 1.35M | 374K | 369K | 330K | 158K | 82K | 91K | 6.26M | 516K | 602K | 720K | 1.32M | 1.29M | 2.42M | 3.62M | 8.69M | 3.46M | 1.6M | 1.6M | 1.6M | 1.9M | 1.4M | 1.3M | 400K |